SUBSCRIBE

Biohealth Innovation Biohealth Innovation
Founding Member of

SUBSCRIBE

BHI Menu

  • Home
  • About Us
  • Programs
  • Partners
  • Portfolio
  • News
  • Events
  • Jobs
  • Contact Us
  • Home
  • About Us
    • BHI Introduction Slide Deck (PDF)
    • Board
    • Team
  • Programs
    • International Soft Landing Assistance
    • Entrepreneur-in-Residence Program
    • Business Resources
    • Non-Dilutive Funding Assistance
  • Partners
  • Portfolio
  • News
    • BHI News Archives
    • BioTalk with Rich Bendis Podcast
  • Events
    • 2021 Forum Videos
  • Jobs
    • Jobs
  • Contact Us

What can BHI do for you?

  • Save the Date & Sponsor the Future: BioHealth Capital Region Week Returns September 23–25, 2025
  • From Classroom to Clinic: Neopenda’s Global Health Journey with CEO Sona Shah on BioTalk
  • Introduction to BHI
  • Entrepreneur-in-Residence Program
  • BioHealth at a Crossroads: Alex Philippidis on Policy Shifts, Investment Trends, and What’s Ahead on BioTalk
  • Soft Landing
  • Save the Date & Sponsor the Future: BioHealth Capital Region Week Returns September 23–25, 2025
  • From Classroom to Clinic: Neopenda’s Global Health Journey with CEO Sona Shah on BioTalk
  • Introduction to BHI
  • Entrepreneur-in-Residence Program
  • BioHealth at a Crossroads: Alex Philippidis on Policy Shifts, Investment Trends, and What’s Ahead on BioTalk
  • Soft Landing

News

  • Senseonics Raises $77.8M Through Public Offering and Private Placement
  • ReGelTec Receives CE Mark for HYDRAFIL® System to Treat Chronic Low Back Pain
  • Quoin Pharmaceuticals Announces FDA Clearance to...
  • GeneDx Publishes Pioneering Vision for Applying AI...
  • HHS layoffs create ‘clear opportunity’ for...
  • Webinar: Turning Uncertainty to Opportunity: Mastering Government Funding in 2025
  • Ashburn's Quoin Pharma’s QRX003 Granted Orphan Drug Status in Europe for Netherton Syndrome
  • REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
  • Altimmune Announces Initiation of RECLAIM Phase 2...
  • Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
  • VPM: Mark Esser wants to make Charlottesville the Silicon Valley of biotech
  • FDA Accepts REGENXBIO’s Application for Priority Review of Gene Therapy for Hunter Syndrome (MPS II)
  • Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital
  • Remedy Plan Therapeutics Raises $18 Million...
  • Maryland Stem Cell Research Fund Awards Over $18 Million to Drive Breakthroughs in Regenerative Medicine
  • View Latest Edition of BHI News »

BHI in the News

  • BioHealth Innovation, Inc.’s Rich Bendis Named Finalist for the Community Builder Award in the 2023 BioHealth Capital Region Annual Awards
MORE

Programs

  • Entrepreneur In Residence Program
  • Non-Dilutive Funding Assistance
  • International Soft Landing Program
MORE

BHI Client News

  • ARPA-H Selects Site for Stakeholder & Operations Hub
MORE

BHI Jobs Board

Check out the wide range of openings currently available in the BioHealth Capital Region.
MORE

Events

28
May
Radiolabeled Sugars for Imaging of Fungal Infections

11:00am - 12:00pm

View Full Calendar

BioTalk Podcast

View All Episodes

BHI Partners

Johnson & Johnson Innovation – JLABS @ Washington, DC
JLL
Alexandria Real Estate Equities, Inc.
BioBuzz
Worksource Montgomery
Economic Alliance of Greater Baltimore
Maryland Tech Council
Rockville Economic Development inc.
Venable
Johns Hopkins University
University System of Maryland
National Institutes of Health
Qiagen
Federal Laboratory Consortium
United Therapeutics
Ernst & Young
M&T Bank
TATRC
Emergent BioSolutions, Inc
Deloitte
GlaxoSmithKline
Aronson, LLC
BD Diagnostics
Kaiser Permanente
City of Frederick
Frederick County Office of Economic Development
Montgomery County Economic Development Corporation
The National Heart, Lung, and Blood Institute
Montgomery County Chamber of Commerce
Maryland Business Incubation Association
WIB-Washington DC/Baltimore
Maryland Department of Commerce
Roche
AstraZeneca
New Enterprise Associates
Noble Life Sciences
DLA Piper
Immunomic Therapeutics, Inc.
Adventist Healthcare
TriBridge Partners

About BHI

BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.

Learn More »

Contact

1 Church Street, Suite 801
Rockville, MD 20850
(301) 637-7950
Email

  • Home
  • | About Us
  • | Programs
  • | Partners
  • | Portfolio
  • | News
  • | Events
  • | Jobs
  • | Contact Us

Copyright © BioHealth Innovation & Delmarva Group, LLC 2020 - All Rights Reserved...

 

Subscribe to BHI Weekly

Name:
Email: BHI Weekly Newsletter